Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kave Moloudi has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Update on Role of Ionizing Radiation to Enhance Proliferation and Differentiation of Normal Stem Cells via Activation of NRF2 Pathway: Review

    by Kave Moloudi, Siamak Haghdoost

    Ionizing radiation (IR) as a stress inducer has a significant impact on various normal stem cells differentiation through activation of various signaling pathways. Low levels of oxidative stress of IR may preserve or even enhance cell differentiation. In response to IR, reactive oxygen species (ROS) can activate various signaling pathways that promote cell differentiation, notably through the involvement of nuclear factor erythroid 2–related factor 2 (NRF2). NRF2 interacts with multiple pathways, including Wnt/β-catenin (osteogenesis), PPARγ (adipogenesis), and BDNF/TrkB (neurogenesis). This response is dose-dependent: low doses of IR activate NRF2 and support differentiation, while high doses can overwhelm the antioxidant system, resulting in cell death. However, the quality of various types of IR, such as proton and carbon ion radiation, may have a varied impact on stem cells (SCs) differentiation compared to X-rays. Hence, activation of the NRF2 signaling pathway in SCs and cell differentiation depends on the level of stress and the quality and quantity of IR. This review is an update to explore how IR modulates SCs fate toward osteogenic, adipogenic, and neurogenic lineages through the NRF2 signaling pathway. We highlight mechanistic insights, dose-dependent effects, and therapeutic implications, bridging gaps between experimental models and clinical translation.


  • Open Access

    Co-delivery of berberine and gold nanoparticles on liposomes for photodynamic therapy against 3D lung cancer cells

    by Kave Moloudi, Heidi Abrahamse, Blassan P. George

    Lung cancer is the second most common cancer diagnosed and is the leading cause of cancer-related deaths globally. Even though there are established lung cancer treatment options including radiotherapy, chemotherapy, and surgery, it remains a great challenge globally. Hence, it is important to explore new procedures such as photodynamic therapy (PDT) to improve the therapeutic outcomes and/or modify established protocol with conventional approaches. PDT is a non-invasive treatment with considerable outcomes in cancer therapy. During PDT, photosensitizer (PS) agents absorb a certain wavelength of laser light and produce reactive oxygen species (ROS), which kill cancer cells. PS agent is one of the critical elements besides the tissue oxygen level and physical parameters of the laser to acheive high treatment efficiency in PDT. Berberine (BBR) has potential as a PS but its free form has some limitations such as limited tumor targeting, poor water solubility and systemic toxicity. However, the objective of this study is the co-delivery of berberine (BBR) and citrate gold nanoparticles (AuNPs) on liposomes (Lipo@AuNPs@BBR) as a new PS compound for PDT on A549 lung cancer spheroid cells. Our hypothesis was that AuNPs can have a synergistic effect on BBR in the Lipo@AuNPs@BBR complex, resulting in more photodamage in PDT on A549 cells. Moreover, liposmes provide a platform for the co-delivery of BBR and AuNPs to cells. Hence, the Lipo@AuNPs@BBR complex was synthesized via the thin-film hydration method, and TEM characterization results showed that the size of the Lipo@AuNPs@BBR complex was 100 nm. Moreover, energy-dispersive X-ray spectroscopy (EDS) confirmed that BBR and AuNPs were co-loaded on liposomes while UV-vis spectroscopy showed that the maximum loading was at concentrations of 14 μM (14%) and 11 μg mL−1 (18.33%) for BBR and AuNPs, respectively. Furthermore, the IC50 (80 μg mL−1) concentration of the Lipo@AuNPs@BBR complex combined with a 405 nm laser at 15 J cm−2 fluency induced cytotoxicity on A549 spheroid cells and resulted in decreasing spheroid cell viability to 34.12%. Finally, the Lipo@AuNPs@BBR complex is not only a potent PS drug in PDT at a safe dose but also considered as a nanotheranositc agent in tumor diagnosis and therapy in vivo studies.


  • Open Access

    Nanotechnology‐mediated photodynamic therapy: Focus on overcoming tumor hypoxia

    by Kave Moloudi, Heidi Abrahamse, Blassan P. George

    The oxygen level in the tumor is a critical marker that determines response to different treatments. Cancerous cells can adapt to hypoxia and low pH conditions within the tumor microenvironment (TME) to regulate tumor metabolism, proliferation, and promote tumor metastasis as well as angiogenesis, consequently leading to treatment failure and recurrence. In recent years, widespread attempts have been made to overcome tumor hypoxia through different methods, such as hyperbaric oxygen therapy (HBOT), hyperthermia, O2 carriers, artificial hemoglobin, oxygen generator hydrogels, and peroxide materials. While oxygen is found to be an essential agent to improve the treatment response of photodynamic therapy (PDT) and other cancer treatment modalities, the development of hypoxia within the tumor is highly associated with PDT failure. Recently, the use of nanoparticles has been a hot topic for researchers and exploited to overcome hypoxia through Oxygen‐generating hydrogels, O2 nanocarriers, and O2‐generating nanoparticles. This review aimed to discuss the role of nanotechnology in tumor oxygenation and highlight the challenges, prospective, and recent advances in this area to improve PDT outcomes.This article is categorized under: Nanotechnology Approaches to Biology > Cells at the Nanoscale Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease


  • Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic

    by Kave Moloudi, Ali Khani, Masoud Najafi, Rasool Azmoonfar, Mehdi Azizi, Houra Nekounam, Mahsa Sobhani, Sophie Laurent, Hadi Samadian

    Radiotherapy is an inevitable choice for cancer treatment that is applied as combinatorial therapy along with surgery and chemotherapy. Nevertheless, radiotherapy at high doses kills normal and tumor cells at the same time. In addition, some tumor cells are resistant to radiotherapy. Recently, many researchers have focused on high‐Z nanomaterials as radiosensitizers for radiotherapy. Among them, gold nanoparticles (GNPs) have shown remarkable potential due to their promising physical, chemical, and biological properties. Although few clinical trial studies have been performed on drug delivery and photosensitization with lasers, GNPs have not yet received Food and Drug Administration approval for use in radiotherapy. The sensitization effects of GNPs are dependent on their concentration in cells and x‐ray energy deposition during radiotherapy. Notably, some limitations related to the properties of the GNPs, including their size, shape, surface charge, and ligands, and the radiation source energy should be resolved. At the first, this review focuses on some of the challenges of using GNPs as radiosensitizers and some biases among in vitro/in vivo, Monte Carlo, and clinical studies. Then, we discuss the challenges in the clinical translation of GNPs as radiosensitizers for radiotherapy and proposes feasible solutions. And finally, we suggest that certain areas be considered in future research.This article is categorized under: Therapeutic Approaches and Drug Discovery > NA


  • Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy

    by Marzieh Keshavarz, Kave Moloudi, Reza Paydar, Ziaeddin Abed, Jaber Beik, Habib Ghaznavi, Ali Shakeri-Zadeh

    The biomedical applications of gold nanoparticles (AuNPs) have experienced rapid growth in recent years, due to their expected benefits in medical imaging and therapy. In this work, we report the development of a theranostic nanocomplex constructed from alginate hydrogel co-loaded with cisplatin and AuNPs (abbreviated as ACA) for simultaneous drug delivery and computed tomography imaging. CT26 cells derived from mouse colon adenocarcinoma were exposed to various concentrations of ACA nanocomplex (for 24 h) and the cytotoxicity was measured using MTT assay. Moreover, the cells treated with ACA nanocomplex were imaged in a computed tomography scanner and the contrast enhancement due to the presence of nanocomplex was assessed. The cytotoxicity results showed that ACA nanocomplex had a more potent chemotherapy efficacy than free cisplatin, so that ACA nanocomplex at the concentration of 5 µg/ml (per cisplatin) and 20 µg/ml of free cisplatin resulted in the same cytotoxicity (survival rate: 66%). The computed tomography imaging study revealed that ACA nanocomplex increased the brightness of computed tomography images, the computed tomography number value, and contrast-to-noise ratio (CNR). ACA nanocomplex can be presented as a computed tomography-traceable nanocarrier that allows to monitor the delivery of therapeutics by assessing their localized accumulation and in vivo biodistribution.


  • Open Access

    Effects of artifact removal on cone-beam computed tomography images

    by Raheleh Emami, Hooriyeh Bashizade Fakhar, Kave Moloudi, Farzaneh Mosavat

    Background: Dental implants and metal fillings may cause artifacts in cone-beam computed tomography (CBCT) images and reduce image quality and anatomic accuracy. The purposes of this study are a subjective evaluation of anatomic landmarks and linear bone measurements after applying artifact removal (low–medium) option on CBCT images. Materials and Methods: In this cross-sectional study, thirty CBCT images from thirty qualified patients were selected in a private radiology center. Low and medium artifact removal was applied to images. Three radiologists assessed the visibility of the mandibular canal, mental foramen, and lamina dura in images. Crestal width and bone length were also measured in three groups of images and was compared by exact McNemar test. ICC test (two-way random model, absolute agreement types) was calculated for comparison of linear bone measurements in three images groups. P ≤ 0.05 was considered statistically significant. Results: Percent agreement of determining mental foramen (outline and location), mandibular canal (outline and location), and lamina dura between three groups of images were 100%, 100%, 83.3%, 96.7%, and 56.6%, respectively. The results of exact McNemar test revealed that medium artifact removal group had a statistical difference in lamina dura observation with none and low artifact removal groups (P < 0.001). Intraclass correlation coefficient showed no statistical differences in crestal width and bone length between groups (P < 0.001). Conclusion: Applying artifact removal does not affect the visibility of large anatomical structures and linear bone measurements, but delicate structures such as lamina dura may become less clear after artifact removal.


  • Open Access

    Synergistic Effects of Arsenic Trioxide and Radiation: Triggering of Intrinsic Pathway of Apoptosis

    by Kave Moloudi, Ali Neshasteriz, Arshad Hosseini, Nazila Eyvazzadeh, Mehdi Shomali, Samira Eynali, Elahe Mirzaei, Asaad Azarnezhad

    The Iranian Biomedical Journal (ISSN 1028-852X) is an international quarterly publication of the Pasteur Institute of Iran.